A Study of the Effect of Dulaglutide on the Action of Warfarin in Healthy Participants

Clinical trial NCT01432938 · COMPLETED

Trial details

NCT number: NCT01432938
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2011-09-01
Primary completion: 2011-12-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.